Chromosomal changes in rheumatoid arthritis patients treated with CPH82

Clinical Rheumatology

Volumn 15, Issue 6, 1996, Pages 584-589

  Rantapaa Dahlqvist S ^a   Nordenson, I ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chromosomal aberration; CPH82; Mutagenic; Podophyllotoxin derivative; Sister chromatid exchange

Indexed keywords

AZATHIOPRINE; CPH 82; CYCLOPHOSPHAMIDE; GOLD SALT; HYDROXYCHLOROQUINE; METHOTREXATE; MITOPODOZIDE; PENICILLAMINE; PODOPHYLLOTOXIN DERIVATIVE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUTAGENESIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; SISTER CHROMATID EXCHANGE;

EID: 0029828184     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02238548     Document Type: Article

References (26)

1. Larsen, A., Peterson, I., Svensson, B. Podophyllum derivatives (CPH82) compared with placebo in the treatment of rheumatoid arthritis. Br J Rheumatol 1989, 28, 124-127.
2. Rantapää Dahlqvist, S., Löfvenberg, E., Norberg, B. Effect of CPH82 in rheumatoid arthritis. Accumulation of bone marrow cells in mitosis and clinical response. Clin Rheumatol 1993, 12, 541-542.
3. Rantapää Dahlqvist, S., Landberg, G., Roos, G., Norberg, B. Cell cycle effects of the anti-rheumatic agent CPH82. Br J Rheumatol 1994, 33, 327-331.
4. Tolchin, S.F., Winkelstein, A., Rodnan, G.P., Pan, S.F., Nankin, H.R. Chromosome abnormalities from cyclophosphamide therapy in rheumatoid arthritis and progressive systemic sclerosis (scleroderma). Arthritis Rheum 1974, 17, 375-382.
5. Palmer, R.G., Dore, C.J., Denman, A.M. Cyclophosphamide induces more chromosome damage than chlorambucil in patients with connective tissue diseases. Quarterly J Med 1986, 59, 395-400.
6. Hunter, T., Urowitz, M.B., Gordon, D.A., Smythe, H.A., Ogryzlo, M.A. Azathioprine in rheumatoid arthritis. Arthritis Rheum 1975, 18, 15-20.
7. Parsons, J.L., Strong, J.S., Fosdick, W.M. The causes of death in patients with rheumatoid arthritis treated with cytotoxic agents. J Rheumatol 1974, 1 (suppl. 1), 75.
8. Kinlen, L.J., Sheil, A.G.R., Peto, J., Doll, R. A collaborative U.K.-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J 1979, 2, 1461-1465.
9. Hazleman, B. Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens. Am J Med 1985, 78 (suppl. 1A), 39-43.
10. Baltus, J.A.M., Boersma, J.W., Hartman, A.P., Vandenbroucke, J.P. The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up. Ann Rheum Dis 1983, 42, 368-373.
11. Baker, G.L., Kahl, L.E., Zee, B.C., Stolzer, B.L., Agarwal, A.K., Medsger, T.A. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study. Am J Med 1987, 83, 1-9.
12. Lewis, P., Hazleman, B.L., Hanka, R., Roberts, S. Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis 1980, 39, 457-461.
13. Silman, A.J., Petrie, J., Hazleman, B., Evans, S.J.W. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study. Ann Rheum Dis 1988, 47, 988-992.
14. Porter, D., Madhok, R., Capell, H. Non-Hodgkin's lymphoma in rheumatoid arthritis. Ann Rheum Dis 1991, 50, 275-276.
15. Prior, P., Symmons, D.P.M., Hawkins, D.F., Scott, D.L. Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis 1984, 43, 128-131.
16. Isomäki, H.A., Hakulinen, T., Joutsenlahti, U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis 1978, 31, 691-696.
17. Gridley, G., McLaughlin, J.K., Ekbom, A., Klareskog, L., Adami, H.-O., Hacker, D.G., Hoover, R., Fraumeni Jr. J.F. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993, 85, 307-311.
18. Tennis, P., Andrews, E., Bombardier, C., Wang, Y., Strand, L., West, R., Tilson, H., Doi, P. Record linkage to conduct an epidemiologic study on the association of rheumatoid arthritis and lymphoma in the province of Saskatchewan, Canada. J Clin Epidemiol 1993, 46, 685-95.
19. Arnett, F.C., Edworthy, S., Block, D.A., et al. The 1987 revised ARA criteria for rheumatoid arthritis. Arthritis Rheum 1988, 31, 315-324.
20. Nordenson, I., Hansson Mild, K., Andersson, G., Sandström, M. Chromosomal aberrations in human amniotic cells after intermittent exposure to fifty Hertz magnetic fields. Bioelectromagnetics 1994, 15, 293-301.
21. ISCN (1985). An international system for human cytogenetic nomenclature. Cytogenet cell genet, Krager, Switzerland.
22. Rantapää Dahlqvist, S., Olsson, T. Interference with the cortisol axis by the microtubule antagonist, CPH82. Br J Rheumatol 1993, 32, 804-806.
23. Hagmar, L., Brögger, A., Hansteen, I.-L., Heim, S., et al. Cancer risk in human predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosomal damage. Cancer research 1994, 54, 2919-2922.
24. Isomäki, H.A., Mutru, O., Koota, K. Death rate and causes of death in patients with rheumatoid arthritis. Scand J Rheumatol 1975, 4, 205-208.
25. ® or parenteral gold. Scand J Rheumatol 1995, 24, 79-84.
26. Kumar, L. Epipodophyllotoxins and secondary leukaemia. Lancet 1993, 342, 819-820.